These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 25055060

  • 1. Eosinophils count and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions.
    Verdoia M, Schaffer A, Barbieri L, Sinigaglia F, Marino P, Suryapranata H, De Luca G, Novara Atherosclerosis Study Group (NAS).
    Atherosclerosis; 2014 Sep; 236(1):169-74. PubMed ID: 25055060
    [Abstract] [Full Text] [Related]

  • 2. Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients.
    Verdoia M, Schaffer A, Barbieri L, Di Giovine G, Marino P, Suryapranata H, De Luca G, Novara Atherosclerosis Study Group (NAS).
    J Diabetes Complications; 2015 Sep; 29(4):517-22. PubMed ID: 25736187
    [Abstract] [Full Text] [Related]

  • 3. Platelet-larger cell ratio and the risk of periprocedural myocardial infarction after percutaneous coronary revascularization.
    Verdoia M, Barbieri L, Schaffer A, Cassetti E, Marino P, Bellomo G, Sinigaglia F, De Luca G, Novara Atherosclerosis Study Group (NAS).
    Heart Vessels; 2015 Jan; 30(1):20-7. PubMed ID: 24297745
    [Abstract] [Full Text] [Related]

  • 4. Platelet distribution width and the risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention.
    Verdoia M, Barbieri L, Schaffer A, Cassetti E, Di Giovine G, Bellomo G, Marino P, Sinigaglia F, De Luca G.
    J Thromb Thrombolysis; 2014 Apr; 37(3):345-52. PubMed ID: 23793523
    [Abstract] [Full Text] [Related]

  • 5. Homocysteine and risk of periprocedural myocardial infarction in patients undergoing coronary stenting.
    Verdoia M, Schaffer A, Barbieri L, Cassetti E, Di Giovine G, Marino P, De Luca G, Novara Atherosclerosis Study Group (NAS).
    J Cardiovasc Med (Hagerstown); 2015 Feb; 16(2):100-5. PubMed ID: 24625566
    [Abstract] [Full Text] [Related]

  • 6. Uric acid and risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention.
    Verdoia M, Schaffer A, Barbieri L, Di Giovine G, Marino P, De Luca G, Novara Atherosclerosis Study Group (NAS).
    Diabetes Metab Res Rev; 2014 May; 30(4):297-304. PubMed ID: 24829966
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mean platelet volume and the risk of periprocedural myocardial infarction in patients undergoing coronary angioplasty.
    Verdoia M, Camaro C, Barbieri L, Schaffer A, Marino P, Bellomo G, Suryapranata H, De Luca G.
    Atherosclerosis; 2013 May; 228(1):136-41. PubMed ID: 23518179
    [Abstract] [Full Text] [Related]

  • 11. Non-HDL cholesterol is a better target for predicting periprocedural myocardial injury following percutaneous coronary intervention in type 2 diabetes.
    Zeng RX, Li XL, Zhang MZ, Guo YL, Zhu CG, Guo LH, Li S, Zhang Y, Li JJ.
    Atherosclerosis; 2014 Dec; 237(2):536-43. PubMed ID: 25463086
    [Abstract] [Full Text] [Related]

  • 12. Association of baseline C-reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: a CACTUS study subanalysis.
    Niccoli G, Sgueglia GA, Latib A, Crea F, Colombo A, CACTUS Study Group.
    Catheter Cardiovasc Interv; 2014 Jan 01; 83(1):E37-44. PubMed ID: 23813627
    [Abstract] [Full Text] [Related]

  • 13. Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.
    Ben-Yehuda O, Chen S, Redfors B, McAndrew T, Crowley A, Kosmidou I, Kandzari DE, Puskas JD, Morice MC, Taggart DP, Leon MB, Lembo NJ, Brown WM, Simonton CA, Dressler O, Kappetein AP, Sabik JF, Serruys PW, Stone GW.
    Eur Heart J; 2019 Jun 21; 40(24):1930-1941. PubMed ID: 30919909
    [Abstract] [Full Text] [Related]

  • 14. Impact of neutrophil-to-lymphocyte ratio on periprocedural myocardial infarction in patients undergoing non-urgent percutaneous coronary revascularisation.
    Verdoia M, Schaffer A, Barbieri L, Di Giovine G, Bellomo G, Marino P, Suryapranata H, De Luca G.
    Neth Heart J; 2016 Jul 21; 24(7-8):462-74. PubMed ID: 27277659
    [Abstract] [Full Text] [Related]

  • 15. Vitamin D deficiency and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions.
    Verdoia M, Ceccon C, Nardin M, Suryapranata H, De Luca G, Novara Atherosclerosis Study Group (NAS).
    Cardiovasc Revasc Med; 2018 Oct 21; 19(7 Pt A):744-750. PubMed ID: 29656938
    [Abstract] [Full Text] [Related]

  • 16. Absolute eosinophils count and the extent of coronary artery disease: a single centre cohort study.
    Verdoia M, Schaffer A, Cassetti E, Di Giovine G, Marino P, Suryapranata H, De Luca G.
    J Thromb Thrombolysis; 2015 May 21; 39(4):459-66. PubMed ID: 25079972
    [Abstract] [Full Text] [Related]

  • 17. Remnant cholesterol predicts periprocedural myocardial injury following percutaneous coronary intervention in poorly-controlled type 2 diabetes.
    Zeng RX, Li S, Zhang MZ, Li XL, Zhu CG, Guo YL, Zhang Y, Li JJ.
    J Cardiol; 2017 Aug 21; 70(2):113-120. PubMed ID: 28209463
    [Abstract] [Full Text] [Related]

  • 18. Relationship of non-cardiac biomarkers with periprocedural myocardial injury in patients undergoing percutaneous coronary intervention.
    Zeng RX, Li JJ, Liao PD, Zhang MZ.
    Int J Cardiol; 2016 Oct 15; 221():726-33. PubMed ID: 27428312
    [Abstract] [Full Text] [Related]

  • 19. MTHFR polymorphism and risk of periprocedural myocardial infarction after coronary stenting.
    Verdoia M, Schaffer A, Cassetti E, Barbieri L, Di Giovine G, Marino P, De Luca G, Novara Atherosclerosis Study Group (NAS).
    Nutr Metab Cardiovasc Dis; 2014 May 15; 24(5):532-7. PubMed ID: 24418373
    [Abstract] [Full Text] [Related]

  • 20. Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI.
    Verdoia M, Secco GG, Barbieri L, Cassetti E, Schaffer A, Sinigaglia F, Marino P, Suryapranata H, De Luca G, Novara Atherosreclerosis Study Group (NAS).
    Platelets; 2014 May 15; 25(5):367-72. PubMed ID: 24283589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.